ArticleActa orthopaedica2016
Implant survival of the most common cemented total hip devices from the Nordic Arthroplasty Register Association database.
Article in Acta orthopaedica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 80 citations in OpenAlex.
- Equivalent hip stem fixation by Hi-Fatigue G and Palacos R + G bone cement: a randomized radiostereometric controlled trial of 52 patients with 2 years' follow-up.Acta orthopaedica · 2019Trial
- Functional Outcomes of Total Hip Arthroplasty using Modified Harris Hip Score and Oxford Hip Score: A Prospective Study.Journal of orthopaedic case reports · 2026Article
- Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Review
- 10-year survival comparison of two cemented implants in primary total hip arthroplasty for osteoarthritis: a New Zealand regional study.Archives of orthopaedic and trauma surgery · 2025Article
- Risk factors influencing periprosthetic fracture and mortality following total hip arthroplasty with a cemented, collarless, polished taper femoral component : a minimum ten-year follow-up cohort study.Bone & joint open · 2025Article
- Total knee arthroplasty revision risks depending on the bone cement used-Data from 50,545 knee replacements of the Catalan Arthroplasty Registry.Journal of experimental orthopaedics · 2025Article
- Increased risk of periprosthetic fracture associated with decreased aseptic loosening in C-stem compared with the Charnley Elite Plus in primary total hip arthroplasty: a minimum 10-year follow-up study.BMC musculoskeletal disorders · 2025Article
- Outcomes of cemented taper slip versus composite beam femoral stems in total hip arthroplasty: A systematic review and meta-analysis.Qatar medical journal · 2025Article
- A comparison of cemented femoral fixation via anterior versus posterior approach total hip arthroplasty: an analysis of 60,739 total hip arthroplasties.Hip international : the journal of clinical and experimental research on hip pathology and therapy · 2024Article
- Experience of an anatomic femoral stem in a UK orthopaedic centre beyond 20 years of follow-up.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024Article
- The utility of cemented femoral stems in modern THA: a 10-year comparative analysis of the Charnley and Exeter stems.Irish journal of medical science · 2024Article
- 60 years of Charnley-Muller Alivium hip prosthesis: the revision percentage and tribo-corrosion sequelae after a mean of 27 years.Archives of orthopaedic and trauma surgery · 2023Article
- The history of the development of the regular straight stem in hip arthroplasty.EFORT open reviews · 2023Review
- Survival and performance of a dual tapered-wedge fully HA-coated press fit femoral stem.Archives of orthopaedic and trauma surgery · 2023Article
- Favorable revision-free survivorship of cemented arthroplasty following failed proximal femoral nail antirotation: a case series with a median follow-up of 10 years.BMC musculoskeletal disorders · 2022Article
- Implant survival of cemented arthroplasty following failed fixation of proximal femoral fractures in patients aged 30-60 years: a retrospective study with a median follow-up of 10 years.BMC musculoskeletal disorders · 2022Article
- Inflammatory tissue reactions around aseptically loose cemented hip prostheses: A retrieval study of the Spectron EF stem with Reflection All-Poly acetabular cup.Journal of biomedical materials research. Part B, Applied biomaterials · 2022Article
- Conversion of failed proximal femoral nail antirotation to uncemented or cemented femoral component fixation: a multicentre retrospective study with a median 10-year follow-up.BMC musculoskeletal disorders · 2022Article
- Cohort analysis of two thousand nine hundred forty-three Link Lubinus SP II cemented total hip arthroplasties from a single hospital with surgeon stratification and twenty six thousand, nine hundred and eighty one component-years of follow-up.International orthopaedics · 2022Article
- Downsizing in total hip arthroplasty. A short stem as a revision implant.Der Orthopade · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 8 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose - According to previous Nordic Arthroplasty Register Association (NARA) data, the 10-year implant survival of cemented total hip arthroplasties (THAs) is 94% in patients aged 65-74 and 96% in patients aged 75 or more. Here we report a brand-level comparison of cemented THA based on the NARA database, which has not been done previously. Patients and methods - We determined the rate of implant survival of the 9 most common cemented THAs in the NARA database. We used Kaplan-Meier analysis with 95% CI to study implant survival at 10 and 15 years, and Cox multiple regression to assess survival and hazard ratios (HRs), with revision for any reason as endpoint and with adjustment for age, sex, diagnosis, and femoral head material. Results - Spectron EF THA (89.9% (CI: 89.3-90.5)) and Elite THA (89.8% (CI: 89.0-90.6)) had the lowest 10-year survivorship. Lubinus (95.7% survival, CI: 95.5-95.9), MS 30 (96.6%, CI: 95.8-97.4), and C-stem THA (95.8%, CI: 94.8-96.8) had a 10-year survivorship of at least 95%. Lubinus (revision risk (RR) = 0.77, CI: 0.73-0.81), Müller (RR =0.83, CI: 0.70-0.99), MS-30 (RR =0.73, CI: 0.63-0.86), C-stem (RR =0.70, CI: 0.55-0.90), and Exeter Duration THA (RR =0.84, CI: 0.77-0.90) had a lower risk of revision than Charnley THA, the reference implant. Interpretation - The Spectron EF THA and the Elite THA had a lower implant survival than the Charnley, Exeter, and Lubinus THAs. Implant survival of the Müller, MS 30, CPT, and C-stem THAs was above the acceptable limit for 10-year survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.